Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
More Patients Set to Benefit as Kanghong Pharmaceutical Targets New Indications with Conbercept 2021-02-03 22:00
Conbercept: New Generation of Product for Treatment of nAMD Completes 36-week Primary Endpoint Visits of Phase III Trial 2020-12-23 22:40
1